Sign In

Also in this Section

Media Contact:

Nola Gruneisen
Phone: 571-292-3068
Email: media@aasld.org

Five Years of Regular Aspirin Use Helps Prevent Common Liver Cancer

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that taking a regular aspirin is associated with a dose-dependent reduction in the risk of hepatocellular carcinoma, one of the most common liver cancers.

Read the press release.

Weight-Loss Surgery Effectively Reduces Weight and Lowers Risk of Post- Liver Transplant Complications in Obese Patients

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that weight-loss surgery prior to liver transplantation is superior to medical weight loss approaches at achieving sustained weight loss, as well as significantly lowering risk of metabolic complications after transplant.

Read the press release.

Clinically Significant Liver Toxicity Related to Anti-Cancer Drugs is Rare but Often Leads to Discontinuation of Treatment

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that patients treated with immune checkpoint inhibitors rarely develop severe liver toxicity, but the majority of those who do permanently stop this cancer treatment. None of the patients developed liver failure as a result of this treatment.

Read the press release.

Liver Cancer Combined with Other Liver Diseases Driving Higher Death Rate and Health Care Costs for US Seniors

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that hospitalizations and death are increasing among Medicare recipients with hepatocellular carcinoma, mainly due to co-existing alcoholic liver disease, hepatitis C virus infection (commonly called HCV) and nonalcoholic fatty liver disease (commonly called NAFLD).

Read the press release.

People with Hepatitis C Who Actively Inject Illegal Drugs Have High Rates of Hepatitis C Treatment Adherence and Cure

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that people who inject drugs who are infected with the hepatitis C virus have high rates of hepatitis C treatment adherence (completion of their treatment), and sustained virologic response.

Read the press release.

African-Americans Face Significant Delays in Liver Transplantation Despite High Priority Scores

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that African-American patients on waitlists for liver transplantation, despite severe disease and high scores for prioritization, persistently face significant disparities and delays in referral.

Read the press release.

Combined Glecaprevir and Pibrentasvir Found Highly Effective in Chronic Hepatitis C Patients Who Have Failed Other Therapies

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found the combination of glecaprevir and pibrentasvir is highly effective and well tolerated in patients with chronic hepatitis C virus (commonly called HCV) genotype-1 infections who have prior treatment experience with sofosbuvir/NS5A inhibitor.

Read the press release.

Universal Hepatitis C Screening of Pregnant Women More Cost-Effective Than Risk-Based Approach

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that universal screening of pregnant women at risk for hepatitis C virus (commonly called HCV) infection is a more efficient and cost-effective diagnostic approach than risk-based screening.

Read the press release.

Nonalcoholic Fatty Liver Disease Patients Have Higher Rates of All Non-Liver-Related Cancers

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that rates of malignancy occurring outside of the liver were higher in adults with nonalcoholic fatty liver disease than among adults across most types of cancers.

Read the press release.

Normothermic Machine Perfusion Can Salvage Fatty Livers for Transplantation

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that using normothermic machine perfusion to preserve steatotic livers leads to altered lipid structure and metabolism and may result in more successful transplantation of these organs.

Read the press release.

Preemptive Antiviral Therapy Prevents Chronic Hepatitis C Infection in Heart Transplant Patients Who Receive Infected Donor Organs

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that pre-emptive administration of pan-genotypic, direct-acting antiviral therapy prevents chronic hepatitis C virus infection in hepatitis C-negative cardiac transplant patients who receive donor hearts infected with the virus.

Read the press release.

Under-Immunization Still a Major Problem in Pediatric Liver Transplant Patient Population

November 9, 2018
Data from a new study presented this week at The Liver Meeting® found that more than half of pediatric liver transplant recipients are under-immunized at the time of their transplant and are at increased risk for vaccine-preventable infections.

Read the press release.